1. Home
  2. IMUX vs ORMP Comparison

IMUX vs ORMP Comparison

Compare IMUX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • ORMP
  • Stock Information
  • Founded
  • IMUX 2016
  • ORMP 2002
  • Country
  • IMUX United States
  • ORMP United States
  • Employees
  • IMUX N/A
  • ORMP N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • ORMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMUX Health Care
  • ORMP Health Care
  • Exchange
  • IMUX Nasdaq
  • ORMP Nasdaq
  • Market Cap
  • IMUX 86.3M
  • ORMP 90.7M
  • IPO Year
  • IMUX N/A
  • ORMP N/A
  • Fundamental
  • Price
  • IMUX $0.98
  • ORMP $2.17
  • Analyst Decision
  • IMUX Strong Buy
  • ORMP Hold
  • Analyst Count
  • IMUX 6
  • ORMP 1
  • Target Price
  • IMUX $12.67
  • ORMP N/A
  • AVG Volume (30 Days)
  • IMUX 1.0M
  • ORMP 113.9K
  • Earning Date
  • IMUX 02-20-2025
  • ORMP 03-05-2025
  • Dividend Yield
  • IMUX N/A
  • ORMP N/A
  • EPS Growth
  • IMUX N/A
  • ORMP N/A
  • EPS
  • IMUX N/A
  • ORMP 0.11
  • Revenue
  • IMUX N/A
  • ORMP N/A
  • Revenue This Year
  • IMUX N/A
  • ORMP N/A
  • Revenue Next Year
  • IMUX N/A
  • ORMP N/A
  • P/E Ratio
  • IMUX N/A
  • ORMP $19.82
  • Revenue Growth
  • IMUX N/A
  • ORMP N/A
  • 52 Week Low
  • IMUX $0.92
  • ORMP $2.00
  • 52 Week High
  • IMUX $2.11
  • ORMP $3.67
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 44.34
  • ORMP 36.05
  • Support Level
  • IMUX $0.94
  • ORMP $2.12
  • Resistance Level
  • IMUX $1.02
  • ORMP $2.27
  • Average True Range (ATR)
  • IMUX 0.06
  • ORMP 0.07
  • MACD
  • IMUX 0.00
  • ORMP -0.01
  • Stochastic Oscillator
  • IMUX 44.96
  • ORMP 22.73

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Share on Social Networks: